Capnography Devices Market Overview 2024-2033 – Competitive Landscape and Strategies

The Capnography Devices Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Capnography Devices Market:
https://www.thebusinessresearchcompany.com/report/capnography-devices-global-market-report

According to The Business Research Company’s Capnography Devices Global Market Report 2024, The capnography devices market size has grown rapidly in recent years. It will grow from $0.66 billion in 2023 to $0.74 billion in 2024 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to the increasing incidence of respiratory diseases, advancements in technology, enhanced patient monitoring, regulatory support and guidelines, and the aging population.

The capnography devices market size is expected to see rapid growth in the next few years. It will grow to $1.17 billion in 2028 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to increasing surgical procedures, growing awareness and training programs, regulatory support and guidelines, and expanding applications. Major trends in the forecast period include increasing healthcare expenditure, growing focus on patient safety, rising awareness and training programs, expansion in home healthcare, and increasing use in intensive care units (ICUs).

The rising prevalence of respiratory diseases is expected to propel the growth of the capnography devices market going forward. Respiratory diseases are a group of medical conditions that affect the lungs and other parts of the respiratory system, including conditions such as asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and lung cancer, which impair breathing and can lead to severe health complications. The prevalence of respiratory diseases is rising due to factors such as increasing air pollution, smoking rates, and aging populations. Capnography devices are used in respiratory diseases to monitor and assess patients’ ventilation status and detect abnormalities in real time. For instance, in February 2024, according to the Canadian Institutes of Health Research, a Canada-based federal agency, respiratory illnesses ranked among the top 10 reasons for hospitalizations, accounting for 32% of all hospitalizations for Canadians aged 0 to 4 in 2022–2023. Hospitalizations for seasonal influenza in children aged 0 to 4 increased to 2,444 in 2022–2023, matching the volumes seen in 2019–2020. Hospital stays for lower respiratory infections, such as acute bronchitis, rose from 9,501 to 19,909, while pneumonia-related hospitalizations nearly tripled, from 3,447 to 9,871. Asthma hospital stays also saw a significant increase, rising by 61% from 3,474 to 5,607. Therefore, the rising prevalence of respiratory diseases is driving the growth of the capnography devices market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=18277&type=smp

The capnography devices market covered in this report is segmented –

1) By Component: Original Equipment Manufacturer (OEM) Modules, Other Components
2) By Product: Hand-held, Stand-alone, Multi-parameter
3) By Technology: Mainstream, Sidestream, Microstream
4) By Application: Emergency Medicine, Pain Management, Procedural Sedation, Critical Care, Other Applications
5) By End-use: Hospitals, Ambulatory Care, Other End-uses

Major companies operating in the capnography devices market are increasing their focus on developing advanced pilot studies to gain a competitive edge in the market. Pilot studies are preliminary research investigations conducted to evaluate the feasibility, effectiveness, and potential impact of these devices in clinical settings. For instance, in March 2024, TidalSense, a UK-based respiratory device company, initiated a pilot study to assess its innovative N-Tidal device for diagnosing asthma in young children. The study, conducted in partnership with the University of Nottingham and Nottingham University Hospitals NHS Trust, will involve 75 children under the age of five who are experiencing asthma and viral wheezing. The N-Tidal device uses capnography technology to measure carbon dioxide levels during normal breathing, eliminating the need for challenging spirometry tests often used in pediatric populations. These traditional tests can be difficult for young children, potentially leading to inaccurate diagnoses and prolonged hospital stays.

The capnography devices market report table of contents includes:

1. Executive Summary
2. Capnography Devices Market Characteristics
3. Capnography Devices Market Trends And Strategies
4. Capnography Devices Market – Macro Economic Scenario
5. Global Capnography Devices Market Size and Growth

.
.
.

32. Global Capnography Devices Market Competitive Benchmarking
33. Global Capnography Devices Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Capnography Devices Market
35. Capnography Devices Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model